SJS Investment Consulting’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23M Buy
19,153
+53
+0.3% +$54.2K 2.5% 5
2026
Q1
$17.6M Buy
19,100
+32
+0.2% +$32.4K 2.15% 6
2025
Q4
$20.5M Buy
19,068
+52
+0.3% +$49.7K 2.59% 6
2025
Q3
$14.5M Buy
19,016
+285
+2% +$212K 1.99% 7
2025
Q2
$14.6M Sell
18,731
-28
-0.1% -$21.8K 2.32% 6
2025
Q1
$15.5M Buy
18,759
+10
+0.1% +$8.32K 2.64% 5
2024
Q4
$14.5M Sell
18,749
-410
-2% -$339K 2.5% 6
2024
Q3
$17M Buy
19,159
+55
+0.3% +$49.4K 3% 3
2024
Q2
$17.3M Buy
19,104
+51
+0.3% +$40.8K 3.35% 3
2024
Q1
$14.8M Buy
19,053
+221
+1% +$157K 2.96% 4
2023
Q4
$11M Sell
18,832
-9
-0% -$5.25K 2.48% 6
2023
Q3
$10.1M Sell
18,841
-51
-0.3% -$26.3K 2.54% 5
2023
Q2
$8.86M Buy
18,892
+53
+0.3% +$22.2K 2.22% 7
2023
Q1
$6.47M Sell
18,839
-145
-0.8% -$48.9K 1.76% 8
2022
Q4
$6.95M Sell
18,984
-104
-0.5% -$36.9K 2.07% 7
2022
Q3
$6.17M Buy
+19,088
New +$6.05M 2.09% 7
2022
Q1
$5.41M Buy
18,895
+112
+0.6% +$28.8K 1.66% 5
2021
Q4
$5.19M Buy
+18,783
New +$4.76M 1.56% 5

Other funds holding LLY

SJS Investment Consulting's LLY Position: Q2 2026 in Review

SJS Investment Consulting increased its Eli Lilly (LLY) stake by 0.28% in Q2 2026, buying an estimated $54.2K and bringing the position to 19,153 shares worth $23M. The position accounts for 2.5% of the portfolio, ranked #5.

SJS Investment Consulting first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. 1,844 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • SJS Investment Consulting held 19,153 shares of Eli Lilly worth $23M as of Q2 2026.
  • SJS Investment Consulting bought 53 Eli Lilly shares in Q2 2026, an estimated $54.2K.
  • Eli Lilly made up 2.5% of SJS Investment Consulting's portfolio in Q2 2026, its #5 holding.
  • SJS Investment Consulting first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • 1,844 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.